Disclosures for "Longitudinal Rates of Brain Atrophy Differ Across Progressive Supranuclear Palsy Clinical Variants "
-
Dr. Kumar has nothing to disclose.
-
Nirubol Tosakulwong has nothing to disclose.
-
Stephen Weigand has nothing to disclose.
-
Dr. Ali has nothing to disclose.
-
Mrs. Stephens has nothing to disclose.
-
The institution of Dr. Machulda has received research support from NIH.
-
The institution of Christopher Schwarz has received research support from NIH.
-
Matthew Senjem has received stock or an ownership interest from Align Technology, Inc.. Matthew Senjem has received stock or an ownership interest from Inovio Biomedical Corp.. Matthew Senjem has received stock or an ownership interest from Johnson & Johnson. Matthew Senjem has received stock or an ownership interest from Mesa Laboratories, Inc.. Matthew Senjem has received stock or an ownership interest from Nvidia Inc.. Matthew Senjem has received stock or an ownership interest from LHC Group, Inc.. Matthew Senjem has received stock or an ownership interest from Natus Medical Incorporated. Matthew Senjem has received stock or an ownership interest from Varex Imaging Corporation. Matthew Senjem has received personal compensation in the range of $100,000-$499,999 for serving as a IT Technical Specialist II with Mayo Clinic.
-
The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
-
Dr. Josephs has nothing to disclose.
-
Dr. Whitwell has nothing to disclose.